Venture-Backed Startups

BioNTech is a biotechnology company developing immunotherapies that use the body's immune system, combining multiple therapeutic modalities and biological targets to treat cancer, infectious diseases, and other serious conditions. It operates globally in the pharmaceutical and biotech industry.

4 investors

Bionure develops next-generation therapies using therapeutic RNA, chemical compounds, peptidomimetics, and oligonucleotides to treat rare neurodegenerative and neuro-inflammatory diseases such as ALS, Rett syndrome, ataxia, and Huntington's disease. Founded in 2009, the company works on drugs for the nervous system spanning pre-clinical through Phase II development.

1 investor

0 investors

Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation mono and multispecific antibodies for severe immune-mediated inflammatory diseases, with an initial focus on atopic dermatitis and inflammatory bowel disease. Its pipeline includes TL1A, TL1A*IL-23p19 bispecific, and IL-25 antibodies with half-life extension technology.

3 investors

BioOra develops and manufactures CAR-T cell therapies from New Zealand, targeting patients with cancer who currently lack access to these treatments in their local regions. The company aims to improve treatment access, reduce delays, and enable scalable delivery of advanced cell therapies across underserved regions globally.

3 investors

Bioo designs, installs, and maintains biotech landscaping projects that generate electricity and water using proprietary technologies. The company develops integrated nature-technology solutions for buildings and urban environments.

1 investor

BioPak supplies certified compostable food and drink packaging — including cups, containers, cutlery and accessories — for quick-service food venues, along with custom-branded packaging options. The company is B Corp certified and ships across Australia.

1 investor

Biopallo is a Finnish company built around a biological/microbiological process technology, with a team including process and technology experts and microbiologists. The page presents company management and board members but does not detail the specific product or end market.

1 investor

BioPharm Communications operates an always-on marketing network reaching over 3 million healthcare decision makers, offering multichannel advertising, trigger-based engagement, and KOL-led educational content for pharmaceutical and healthcare brands. It provides targeted campaign activation, medical journal partnerships, and measurement tools to help brands reach and educate HCPs.

1 investor

0 investors

0 investors

Biopharm is a pharmaceutical company founded in 1992 that manufactures and distributes medications and medical devices in Algeria. The company serves the Algerian healthcare market and is a major player in the country's pharmaceutical industry.

1 investor

0 investors

BioPhenoMA develops a protein detection technology platform based on its proprietary TN-cyclon (improved enzyme cycling method) to quantify ultra-trace amounts of proteins in real biological samples while preserving their structure and localization. It targets biomedical and life-science researchers analyzing the mechanisms of biological phenomena.

1 investor

Biophilica is a biotechnology company that develops Treekind, a 100% biobased, plastic-free material for the fashion, footwear, packaging, furniture, homeware and automotive industries. The material is certified biobased and vegan, offered as an alternative to petrochemical-based products.

2 investors

0 investors

Biophoundry develops phage-based technologies for therapeutics, diagnostics, and bio-molecular engineering, including its Phax platform aimed at making phage therapy faster and more affordable. The company focuses on precision antibiotics to address antimicrobial resistance, combining synthetic biology, robotics, and data science.

0 investors

0 investors

BioPhy builds a suite of modular AI tools for pharmaceutical companies, automating quality, compliance, manufacturing, and supply-chain tasks such as SOP–regulation gap analysis, document consolidation, and IQ/OQ/PQ validation. Its platform targets pharma quality operations, manufacturing, and validation teams to reduce manual documentation and review work.

1 investor

0 investors

Biophyx Surgical develops surgical retraction technologies, working with surgeons and stakeholders to create medical devices aimed at improving surgical outcomes. The company operates in the surgical medical device sector, drawing on experience in device R&D, regulatory, and intellectual property.

0 investors

BioPlaster produces compostable and biodegradable packaging—including cushioning foam (GreenShell), packaging films, and reusable bags—made primarily from brown seaweed (sargassum) biomass. It targets businesses seeking sustainable alternatives to conventional plastic for applications like delivery, shopping, and secondary packaging.

4 investors

0 investors

BioPoly develops orthopedic implants made from a proprietary self-lubricating biomaterial that combines hyaluronic acid and ultrahigh molecular weight polyethylene to replace damaged cartilage. Its products, including toe, radial head, and knee implants, target cartilage defects for surgeons and patients as a minimally invasive alternative between biological treatments and total joint replacement.

0 investors